Cytokine Levels in the Body Fluids of a Patient With COVID-19 and Acute Respiratory Distress Syndrome: A Case Report

Documenti analoghi

• IL-6 may be a good biomarker for earlier detection of COVID-19 progression
  di: Wang, Changsong, et al.
  Pubblicazione: (2020)
• Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
  di: Hashemian, Seyed MohammadReza, et al.
  Pubblicazione: (2021)
• Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
  di: Seyed MohammadReza Hashemian, et al.
  Pubblicazione: (2021-11-01)
• Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls
  di: Bauer, T., et al.
  Pubblicazione: (2000)
• Plasma Cytokine Levels Fall in Preterm Newborn Infants on Nasal CPAP with Early Respiratory Distress
  di: Carvalho, Clarissa Gutierrez, et al.
  Pubblicazione: (2015)